Glucagon-Like Peptide-1 (GLP-1) Suppression of Alpha Cell Secretion in Type 2 Diabetes Mellitus (T2DM)

NCT00862589 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Hyperglycemia
Hyperglucagonemia
Glucose Intolerance

Interventions

OTHER: GLP-1 infusion

Sponsor

University Hospital, Gentofte, Copenhagen

Collaborators

[object Object]